KL-6, a serum marker for interstitial pneumonitis, was evaluated in patients with Pneumocystis carinii pneumonia (PCP). Patient 1 was a 56-year-old womanwith rheumatoid arthritis treated with immunosuppressive drugs and corticosteroids. Patient 2 was a 59-year-old man with a glioblastoma who received anti-cancer drugs and corticosteroids. In both patients, serum KL-6 showed an abnormally high level due to the complication of PCP, and it decreased following successful treatment. These results indicate that PCPis one of the diseases in which serum increases.
Introduction
Pneumocystis carinii pneumonia (PCP) is a life-threatening opportunistic infection associated with suppressed cellular immunity in patients with acquired immunodeficiency syndrome (AIDS) and anti-cancer and immunosuppressive therapy (1, 2) . Pulmonary infection with P. carinii is associated with histologic findings of interstitial pneumonitis and irreversible fibrotic changes (3, 4) . KL-6, a human MUCImucin (5-7), has been reported to be a sensitive serum markerfor interstitial pneumonitis (8) (9) (10) (11) (12) (13) (14) (15) .
Here we evaluated the usefulness of serum KL-6 as a marker for the development of PCP in immunocompromised hosts. Because of nausea and general fatigue, however, it was changed four days later to inhaled pentamidine isetionate at 4 mg/kg. Improvements ofdyspnea, the chest radiograph, and hypoxemia were observed on day 14 of pentamidine isetionate. The alveolar-arterial oxygen difference (AaDO2) normalized from 41.0 mmHg to 18.7 mmHg and the serum KL-6 level decreased to 2,200 U/ml on September 9.
Patient 2
A 59-year-old man was given 80 mg of nimustine hydrochloride (ACNU)for a glioblastoma. He complained of fever and dyspnea four weeksafter receiving 3 mg per day of betamethasone to reduce his brain edema, and was admitted to National Kinki-Chuo Hospital for Chest Diseases on July 19, 1994 . On admission, fine crackles were heard and a chest radiograph showed bilateral interstitial shadows. The leukocyte count was 2,900 cells/jiil (24.0% lymphocytes). Serum KL-6, CRP and LDH levels were 2,000 U/ml, 3.2 mg/dl and 1,372 IU/ /, respectively. Arterial blood gas analysis on room air showed a hypoxemia with PaO2 of 48.0 mmHg.Anti-cytomegalovims immunoglobulin M (IgM) antibody was not detectable, but P. carinii was detected cytologically in the BALF (Fig. 2A ). The KL-6 level in BALFwas 4,800 U/ml. Methylprednisolone and TMP-SMX were administered followed by the administration of pentamidine isetionate (intravenously and by inhalation) (Fig. 3) . The serum KL-6 level increased to 6,600 U/ml until inhaled pentamidine isetionate was started, and then gradually decreased. His dyspnea and chest radiographic findings were improved remarkably and his AaDO2 decreased from 80.9 mmHgto 18.1 mmHg.
Tissue specimens of the transbronchial lung biopsy performed on the day of admission showed interstitial pneumonitis. Immunohistochemical examination of the tissue revealed that KL-6 was produced by hyperplastic pneumocytes (Fig.   2B ).
Discussion
The present patients showed a remarkably elevated level of KL-6, and suggest that KL-6 maybe a useful serum marker in the evaluation ofPCP in immunocompromised hosts. In patient KL-6 in P. carinii Pneumonia ,000-4,000-^^^^\s^^"4-°2
,000-2,000- 1, the unexpected increase of serum KL-6 level following the administration of a high dose of corticosteroids raised the suspicion ofPCP. In patient 2, the similar increase of serum KL-6 led to the diagnosis of PCP. In both patients, the KL-6 level decreased after succes sful treatment with pentamidine isetionate. Though PCP occurred in patients receiving immunosuppressive drugs, Kawakami et al (16) have reported that KL-6 might be useful in the diagnosis ofPCP in patients with AIDS.
KL-6 was immunohistochemically expressed on hyperplastic pneumocytes in patient 2 and in the patient reported by Kawakami et al. This histologic finding is commonin diseases in which serum KL-6 is increased (8, 9) . KL-6 is not a specific marker for PCP, because serum KL-6 level is frequently increased in diseases such as idiopathic pulmonary fibrosis, hypersensitivity pneumonitis, radiation pneumonitis, sarcoidosis with lung involvement, and interstitial pneumonitis in collagen vascular diseases. Serum KL-6 is not increased in patients with bacterial pneumonia ( 17) . Since serum KL-6 is associated with alveolarcapillary permeability changes caused by alveolar epithelial cell injury in berylliosis (18) , serum KL-6 levels might reflect the degree of epithelial cell injury also in interstitial lung diseases including PCP. Furthermore, KL-6 existing in pulmonary epithelial lining fluids might cause the intra-alveolar fibrosis in these diseases, because KL-6 is one of the chemotactic factors for human fibroblasts (19) . Further study is necessary to determine whether KL-6 is useful in the diagnosis ofPCP, especially in patients with AIDS and in patients on immunosuppressive therapy.
